About Lotus Tissue Repair, Inc.
Company Website: https://www.lotustissuerepair.com
Lotus Tissue Repair is developing its proprietary recombinant human collagen Type VII (rC7) technology as a treatment for dermatologic conditions in which rC7 may play an important role in accelerating chronic wound healing, such as diabetic foot ulcers, venous stasis ulcers and similar conditions.
Current Openings
Lotus Tissue Repair, Inc. has no jobs listed. Checkout our job board for opportunities at top VC-backed startups.